Cargando…

PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer

OBJECTIVES: The role of programmed cell death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), especially according to histologic type, remains controversial. The purpose of this study was to assess PD-L1 expression and its association with overall survival (OS) and clinicopathologic characte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Cuiling, Tang, Jianjun, Sun, Huanhuan, Zheng, Xiaobin, Li, Zhanyu, Sun, Tiantian, Li, Jie, Wang, Shuncong, Zhou, Xiuling, Sun, Hongliu, Cheng, Zhibin, Zhang, Hongyu, Ma, Haiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601666/ https://www.ncbi.nlm.nih.gov/pubmed/28938570 http://dx.doi.org/10.18632/oncotarget.17022

Ejemplares similares

Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages
por: Wang, Shuncong, et al.
Publicado: (2017)

Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis
por: Zhou, Cuiling, et al.
Publicado: (2016)

Survival changes in Patients with Synovial Sarcoma, 1983-2012
por: Wang, Shuncong, et al.
Publicado: (2017)

Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983–2012
por: Wang, Shuncong, et al.
Publicado: (2016)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

N6-Methyladenosine (m(6)A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
por: Zhou, Yang, et al.
Publicado: (2022)

Trend in relative survival in squamous cervical cancer by decade from 1983 to 2012: a period analysis
por: Wu, Jinna, et al.
Publicado: (2018)

Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis
por: Zhou, Xiuling, et al.
Publicado: (2018)

NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022)

Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022)

Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984–2013
por: Haiyu, Zhang, et al.
Publicado: (2019)

Survival improvement in patients with pancreatic cancer by decade: A period analysis of the SEER database, 1981–2010
por: Sun, Huanhuan, et al.
Publicado: (2014)

Angiotensin-converting Enzyme Inhibitors Decrease the Incidence of Radiation-induced Pneumonitis Among Lung Cancer Patients: A Systematic Review and Meta-analysis
por: Sun, Fengze, et al.
Publicado: (2018)

The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981–2010
por: Lu, Guanming, et al.
Publicado: (2018)

Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012
por: Wu, Jinna, et al.
Publicado: (2018)

Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease
por: Li, Juyi, et al.
Publicado: (2023)

High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation
por: LIU, LU, et al.
Publicado: (2023)

Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma
por: Liu, Zhenhua, et al.
Publicado: (2020)

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis
por: Zhu, Lei, et al.
Publicado: (2019)

DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection
por: Wang, Shuncong, et al.
Publicado: (2020)

Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
por: Zhang, Yaxiong, et al.
Publicado: (2018)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer
por: Liu, Chengming, et al.
Publicado: (2022)

PSMA1, a Poor Prognostic Factor, Promotes Tumor Growth in Lung Squamous Cell Carcinoma
por: Liu, Zhao, et al.
Publicado: (2023)

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
por: Qin, Hui, et al.
Publicado: (2019)

Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
por: Sun, Xiaoyu, et al.
Publicado: (2021)

PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer
por: Yu, Hui, et al.
Publicado: (2021)

Prognostic value of poorly differentiated clusters in invasive breast cancer
por: Sun, Ying, et al.
Publicado: (2014)

Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987–2016
por: Wang, Jingxuan, et al.
Publicado: (2021)

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases
por: Sun, Chenglong, et al.
Publicado: (2020)

MeImmS: Predict Clinical Benefit of Anti-PD-1/PD-L1 Treatments Based on DNA Methylation in Non-small Cell Lung Cancer
por: Shang, Shipeng, et al.
Publicado: (2021)

Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy
por: Jiang, Shanshan, et al.
Publicado: (2022)

Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
por: Kim, Hae Su, et al.
Publicado: (2016)

Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma
por: Yu, Jianjun, et al.
Publicado: (2017)

Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients
por: Gu, Xiaobin, et al.
Publicado: (2016)

Survival improvement by decade of patients aged 0–14 years with acute lymphoblastic leukemia: a SEER analysis
por: Ma, Haiqing, et al.
Publicado: (2014)

Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade
por: Han, Si-Chong, et al.
Publicado: (2023)

Case Report: Replacement of PD-1 inhibitors with PD-L1 inhibitors in the treatment of squamous non-small-cell lung carcinoma
por: Wu, Tong, et al.
Publicado: (2023)

Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma
por: Ma, Jie, et al.
Publicado: (2015)

Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_12ef9qt9lil27j6oj292ddv9u3